195 related articles for article (PubMed ID: 36700242)
1. Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study.
Pedersini R; Cosentini D; Rinaudo L; Zamparini M; Ulivieri FM; di Mauro P; Maffezzoni F; Monteverdi S; Vena W; Laini L; Amoroso V; Simoncini EL; Farina D; Mazziotti G; Berruti A
Bone Rep; 2023 Jun; 18():101654. PubMed ID: 36700242
[TBL] [Abstract][Full Text] [Related]
2. Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study.
Pedersini R; Monteverdi S; Mazziotti G; Amoroso V; Roca E; Maffezzoni F; Vassalli L; Rodella F; Formenti AM; Frara S; Maroldi R; Berruti A; Simoncini E; Giustina A
Bone; 2017 Apr; 97():147-152. PubMed ID: 28104509
[TBL] [Abstract][Full Text] [Related]
3. Does hip structural analysis confer additional benefit to routine BMD assessment in postmenopausal women with hip fracture? A study from a tertiary center in southern India.
Johnson JT; Cherian KE; Kapoor N; Jebasingh FK; Asha HS; Mathai T; Nithyananth M; Oommen AT; Daniel AJ; Thomas N; Paul TV
Arch Osteoporos; 2022 Feb; 17(1):32. PubMed ID: 35122523
[TBL] [Abstract][Full Text] [Related]
4. Cortical thickness in the intertrochanteric region may be relevant to hip fracture type.
Zhuang H; Li Y; Lin J; Cai D; Cai S; Yan L; Yao X
BMC Musculoskelet Disord; 2017 Jul; 18(1):305. PubMed ID: 28720137
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
Hong AR; Kim JH; Lee KH; Kim TY; Im SA; Kim TY; Moon HG; Han WS; Noh DY; Kim SW; Shin CS
Osteoporos Int; 2017 Apr; 28(4):1413-1422. PubMed ID: 28083668
[TBL] [Abstract][Full Text] [Related]
6. The effects of abaloparatide on hip geometry and biomechanical properties in Japanese osteoporotic patients assessed using DXA-based hip structural analysis: results of the Japanese phase 3 ACTIVE-J trial.
Sone T; Ohnaru K; Sugai T; Yamashita A; Okimoto N; Inoue T; Matsumoto T
Arch Osteoporos; 2023 Nov; 18(1):146. PubMed ID: 38030806
[TBL] [Abstract][Full Text] [Related]
7. The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy.
Monteverdi S; Pedersini R; Gallo F; Maffezzoni F; Dalla Volta A; Di Mauro P; Turla A; Vassalli L; Ardine M; Formenti AM; Simoncini EL; Giustina A; Maroldi R; Amoroso V; Berruti A
JBMR Plus; 2021 Feb; 5(2):e10440. PubMed ID: 33615109
[TBL] [Abstract][Full Text] [Related]
8. Bone geometry and strength adaptations to physical constraints inherent in different sports: comparison between elite female soccer players and swimmers.
Ferry B; Duclos M; Burt L; Therre P; Le Gall F; Jaffré C; Courteix D
J Bone Miner Metab; 2011 May; 29(3):342-51. PubMed ID: 20963459
[TBL] [Abstract][Full Text] [Related]
9. Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer.
Cosentini D; Pedersini R; Di Mauro P; Zamparini M; Schivardi G; Rinaudo L; Di Meo N; Delbarba A; Cappelli C; Laganà M; Alberti A; Baronchelli M; Guerci G; Laini L; Grisanti S; Simoncini EL; Farina D; Mazziotti G; Berruti A;
JAMA Netw Open; 2024 Jan; 7(1):e2350950. PubMed ID: 38198137
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of teriparatide, denosumab and zoledronate on hip structural and mechanical parameters in osteoporosis; a real-life study.
Jaarah N; Lam CFJ; Lodhia N; Dulnoan D; Moore AE; Hampson G
J Endocrinol Invest; 2024 Jan; ():. PubMed ID: 38191946
[TBL] [Abstract][Full Text] [Related]
11. Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.
Antonini S; Pedersini R; Birtolo MF; Baruch NL; Carrone F; Jaafar S; Ciafardini A; Cosentini D; Laganà M; Torrisi R; Farina D; Leonardi L; Balzarini L; Vena W; Bossi AC; Zambelli A; Lania AG; Berruti A; Mazziotti G
J Endocrinol Invest; 2024 Feb; 47(2):433-442. PubMed ID: 37592052
[TBL] [Abstract][Full Text] [Related]
12. Negative Impact of Aromatase Inhibitors on Proximal Femoral Bone Mass and Geometry in Postmenopausal Women with Breast Cancer.
Lee SJ; Kim KM; Brown JK; Brett A; Roh YH; Kang DR; Park BW; Rhee Y
Calcif Tissue Int; 2015 Dec; 97(6):551-9. PubMed ID: 26232103
[TBL] [Abstract][Full Text] [Related]
13. Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis.
Sone T; Kon N; Gaither KW; Okubo N; Osakabe T; Nakayama Y; Fukunaga M; Ito M; Nakamura T
Bone Rep; 2017 Dec; 7():164-171. PubMed ID: 29188222
[TBL] [Abstract][Full Text] [Related]
14. Influence of the weight status on hip bone strength indices in a group of sedentary adolescent girls.
El Hage R; El Hage Z; Moussa E; Baddoura R; Theunynck D; Jacob C
J Med Liban; 2012; 60(1):30-6. PubMed ID: 22645899
[TBL] [Abstract][Full Text] [Related]
15. Bone cross-sectional geometry is not associated with atypical femoral fractures in Asian female chronic bisphosphonate users.
Chou AC; Ng AC; Png MA; Chua DT; Ng DC; Howe TS; Koh JS
Bone; 2015 Oct; 79():170-5. PubMed ID: 26067179
[TBL] [Abstract][Full Text] [Related]
16. Geometric indices of hip bone strength in overweight and control elderly men.
El Hage R; Theunynck D; Rocher E; Baddoura R
J Med Liban; 2014; 62(3):150-5. PubMed ID: 25306795
[TBL] [Abstract][Full Text] [Related]
17. Age trends for hip geometry in Chinese men and women and the association with femoral neck fracture.
Zhang H; Hu YQ; Zhang ZL
Osteoporos Int; 2011 Sep; 22(9):2513-22. PubMed ID: 21210083
[TBL] [Abstract][Full Text] [Related]
18. Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.
Ito M; Nakamura T; Fukunaga M; Shiraki M; Matsumoto T
Bone; 2011 Sep; 49(3):328-34. PubMed ID: 21605716
[TBL] [Abstract][Full Text] [Related]
19. Geometric indices of hip bone strength in obese, overweight, and normal-weight adolescent boys.
El Hage R
Osteoporos Int; 2012 May; 23(5):1593-600. PubMed ID: 21881968
[TBL] [Abstract][Full Text] [Related]
20. Effects of gender, anthropometric variables, and aging on the evolution of hip strength in men and women aged over 65.
Kaptoge S; Dalzell N; Loveridge N; Beck TJ; Khaw KT; Reeve J
Bone; 2003 May; 32(5):561-70. PubMed ID: 12753873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
